U.S., Jan. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07313124) titled 'Comparative Study Between Antihyperlipidemic Agents in Treatment of Cardiovascular Diseases' on Dec. 17, 2025.
Brief Summary: The goal of this clinical trial is to study the efficiency and safety of using combinations of antihyperlipidemic agents with a single drug to treat cardiovascular diseases.
The main questions it aims to answer are:
* Which approach is more effective rosuvastatin monotherapy or rosuvastatin ezetimibe combination antihyperlipidemic for patients with cardiovascular diseases (CVDs)?
* What medical problems do participants could when taking antihyperlipidemic drugs? Researchers will compare rosuvastatin 20 mg o...